Drug is third with breakthrough therapy designation to receive FDA approval The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is the first drug that has demonstrated safety
Read More...
Read the complete post at http://feedproxy.google.com/~r/aids/gov/~3/5Q7ai3CxrXU/fda-approves-sovaldi-for-chronic-hepatitis-c.html
Posted
Dec 09 2013, 10:55 AM
by
AIDS.gov blog